Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment
Clinical trial NCT02802345 · COMPLETED
Trial details
- NCT number
- NCT02802345
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-30
- Primary completion
- 2017-12-19
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.